# A Trial of SHR-1316 Maintenance Therapy for Limited Stage Small Cell Lung Cancer

> **NCT04647357** · PHASE2 · UNKNOWN · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 60 (estimated)

## Conditions studied

- Limited-stage Small Cell Lung Cancer, LS-SCLC

## Interventions

- **DRUG:** SHR-1316

## Key facts

- **NCT ID:** NCT04647357
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-27
- **Primary completion:** 2023-05-27
- **Final completion:** 2023-12-27
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04647357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04647357, "A Trial of SHR-1316 Maintenance Therapy for Limited Stage Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04647357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*